Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
about
The AP-2 family of transcription factorsIdentification of target genes of transcription factor activator protein 2 gamma in breast cancer cellsAP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cellsEtiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosisTranslational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 clusterInvolvement of transcription factor activator protein-2alpha in doxazosin-induced HeLa cell apoptosis.Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyteIntratubular germ cell neoplasia of the human testis: heterogeneous protein expression and relation to invasive potential.Hanging drop cultures of human testis and testis cancer samples: a model used to investigate activin treatment effects in a preserved niche.Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell linesSulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.Ex vivo culture of human fetal gonads: manipulation of meiosis signalling by retinoic acid treatment disrupts testis development.Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasiaGene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures.BMP signaling in the human fetal ovary is developmentally regulated and promotes primordial germ cell apoptosisN-cadherin expression in malignant germ cell tumours of the testisDevelopmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.Improved gene expression signature of testicular carcinoma in situ.Curcumin inhibits AP-2γ-induced apoptosis in the human malignant testicular germ cells in vitroComparative proteomics of human embryonic stem cells and embryonal carcinoma cells.Transcription factor TFAP2C regulates major programs required for murine fetal germ cell maintenance and haploinsufficiency predisposes to teratomas in male miceGenome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors.Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markersInhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristicsIs human fecundity declining?From embryonic stem cells to testicular germ cell cancer-- should we be concerned?What Is Trophoblast? A Combination of Criteria Define Human First-Trimester TrophoblastTranscriptional analysis of human cranial compartments with different embryonic origins.Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations.Current approaches for detection of carcinoma in situ testis.Germ cell differentiation in the marmoset (Callithrix jacchus) during fetal and neonatal life closely parallels that in the human.Testicular dysgenesis syndrome and the origin of carcinoma in situ testis.Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.Biology of testicular germ cell tumors.Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.Ibuprofen results in alterations of human fetal testis development.Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management optionsThe role of BLIMP1 and its putative downstream target TFAP2C in germ cell development and germ cell tumours.
P2860
Q21184171-11753ABB-A4D0-41F1-99C1-BB78FF4194DEQ21260382-AE1C7A72-47EB-402D-967C-DE408D2EAE47Q24676129-EF8A1BFC-E584-460F-B5E2-627A51BDE0CBQ26991452-38D55DD7-817C-4946-A68E-A66BA9530013Q28283064-1C71C8BA-E86D-452B-B05E-CC353FD57DEAQ33325035-A9222EF4-D33D-4E96-8173-0D5173202BA3Q33459014-237734CA-256A-4C8E-A762-45FE59A6D3BBQ33577961-099CA650-3E8B-4509-85E9-E7E339B19F01Q33613573-3C5E4B65-3C1F-4C0F-A031-768E9F509D32Q33700563-C2C5D6B9-F410-4500-B4D9-D31988DBF7ACQ33842071-642CF99A-5AF9-433C-92A6-637E8CA3B23BQ33896475-31A40889-6108-4181-9A94-15ADFD562196Q33909618-9A794B3A-FF89-4305-B653-40C0BD31C744Q33968214-24F11A39-3939-4B33-B906-5B55F19E48CDQ34202111-FDC26D8A-6BEF-4D21-934F-6074437CF030Q34243004-9FA7F689-015B-4034-8088-C9BEC0F3E57CQ34445653-F3EA28F2-6B2B-47BF-A0D1-1C1602AD03FFQ34502475-3B8F5F9D-0D04-4EFF-B117-2A2BE2B5FD6DQ34626534-62B2BAC6-8A54-442E-AC1C-8AFE10DF77CFQ34728103-2ECF7C5D-C212-4B54-A085-1E39015676EAQ34910536-CF0A2463-5E19-48D5-92C3-2688D0C8B897Q34963433-A72153E8-12FA-4427-A8ED-FB0C3D779DD6Q35598887-5A6D692C-4A9C-4F73-83DF-5F40600220A2Q35634176-8C6E385F-03B4-4BDF-A2E2-11C11B25D765Q36344857-2F3969A9-E009-49F1-ABA7-E6A0CB07B6ECQ36391001-CB502CAD-E93F-425D-8F85-D20CA65AB2C3Q36391085-8A25F530-B126-4D73-844A-8BFA1FD166FBQ36570125-2AEB39FF-7B55-4773-9D45-E349F0A09A86Q36572550-F5F7B8CD-E6C0-4824-8EE4-028A99B1A770Q36748207-9B65DFBE-7C11-40E7-8B85-35C99A9EEBE1Q36913139-10FDA703-515E-4C27-9512-E3035C48EAE0Q36913156-8E87D455-D1D8-4F0B-B82B-2C7A1F6BF123Q36975035-8525D9C4-4B19-4C60-81C7-5C1F673085ACQ37060508-ECB7F58D-5D28-43C8-9CF7-FC57FAE1C5DDQ37209628-621F06E3-73F3-46FB-A028-EE20214AA750Q37300035-D5CFF905-4686-45F9-AA58-F631451C3437Q37644981-B657511C-FC37-432D-9796-873A15DDA236Q37692388-FE267126-85DE-4EAB-8600-A2A4C25BDE04Q37763851-140DED78-17A0-40FA-8741-C2AFECCE29D9Q37874665-79671BAA-CFBB-4BDE-A3DE-ADE8FE5B61DA
P2860
Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Transcription factor AP-2gamma ...... in situ and germ cell tumors.
@en
type
label
Transcription factor AP-2gamma ...... in situ and germ cell tumors.
@en
prefLabel
Transcription factor AP-2gamma ...... in situ and germ cell tumors.
@en
P2093
P50
P1476
Transcription factor AP-2gamma ...... in situ and germ cell tumors.
@en
P2093
Christina E Hoei-Hansen
Henrik Leffers
John E Nielsen
Niels Graem
Si Brask Sonne
P304
P356
10.1158/1078-0432.CCR-04-1285
P407
P577
2004-12-01T00:00:00Z